Supplementary Table 1 from A Phase I Dose–Escalation Study of Regorafenib (BAY 73–4506), an Inhibitor of Oncogenic, Angiogenic, and Stromal Kinases, in Patients with Advanced Solid Tumors
| Autor: | Olaf Christensen, Oliver Boix, Roland Heinig, Jörn Krätzschmar, Clemens Unger, Ulrike Fasol, Martin Büchert, Susanne Hedbom, Simone Steinbild, Annette Frost, Klaus Mross |
|---|---|
| Rok vydání: | 2023 |
| Popis: | PDF file, 52KB, Adverse events that led to permanent treatment discontinuation. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|